According to our (Global Info Research) latest study, the global IVUS-OCT market size was valued at US$ 32.47 million in 2025 and is forecast to a readjusted size of US$ 124 million by 2032 with a CAGR of 19.4% during review period.
IVUS-OCT is a medical device that combines intravascular ultrasound imaging (IVUS) and optical coherence tomography (OCT) for image acquisition and diagnosis within blood vessels.
IVUS and OCT are two commonly used vascular imaging techniques that provide high-resolution images of vascular structure and dynamic data, helping physicians assess vascular lesions, the degree of stenosis, and procedures such as stent placement. Combining IVUS and OCT in a single device allows for the simultaneous acquisition of the advantages of both imaging modalities, providing a more comprehensive vascular assessment and diagnostic capability.
On the supply side, global production is highly concentrated in China and the United States, with no meaningful output from other regions through 2031. In the initial commercialization phase, U.S. output accounted for 100% of production value and units in 2020–2021, but from 2022 onward Chinese manufacturing rapidly became dominant as Panovision and other domestic hybrid IVUS-OCT platforms moved from registration into scaled deployment. By 2025, China contributed over 90% of global production value and units, while the U.S. share fell to mid-single digits. Looking forward, the model assumes that U.S. and other ex-China roll-outs accelerate from 2026, so that by 2031 China still retains roughly two-thirds of global production value and volume, but the U.S. share rises to around one-third, and “Rest of World” remains marginal.
The competitive landscape is narrow and technology-intensive. Over the historical window 2020–2025, essentially all commercial production is attributed to six manufacturers: Conavi Medical Inc (Canada), Grand Pharmaceutical, Panovision, Terumo, Horimed Technology Co., Ltd and InnerMedical Co., Ltd. The Chinese players collectively dominate global unit output and production value, leveraging local manufacturing, regulatory approval by NMPA and bundling strategies in high-value consumable tenders, while Conavi and Terumo act as the leading non-Chinese innovators with footprints in North America, Japan and selected international markets. Market share tables and price curves for 2020–2025 confirm a highly concentrated structure with limited new entrants and no meaningful contribution from general imaging OEMs or catheter OEMs without their own console platforms.
Overall, the research supports a conclusion that hybrid IVUS-OCT will remain a fast-growing but structurally niche segment of the global cardiovascular device market through 2031. The technology will be concentrated in high-volume cath labs and complex PCI centers, with China and the U.S./Canada accounting for the vast majority of installations and revenue, and a small group of specialized manufacturers capturing most of the value.
This report is a detailed and comprehensive analysis for global IVUS-OCT market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IVUS-OCT market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global IVUS-OCT market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global IVUS-OCT market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global IVUS-OCT market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IVUS-OCT
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IVUS-OCT market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Panovision Medical, Conavi Medical, Grand Pharmaceutical, Horimed Care, Terumo, InnerMedical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IVUS-OCT market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
36 mm/s Retraction Speed
25 mm/s Retraction Speed
10 mm/s Retraction Speed
Others
Market segment by Application
Public Hospitals
Private Hospitals
Major players covered
Panovision Medical
Conavi Medical
Grand Pharmaceutical
Horimed Care
Terumo
InnerMedical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IVUS-OCT product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IVUS-OCT, with price, sales quantity, revenue, and global market share of IVUS-OCT from 2021 to 2026.
Chapter 3, the IVUS-OCT competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IVUS-OCT breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IVUS-OCT market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IVUS-OCT.
Chapter 14 and 15, to describe IVUS-OCT sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on IVUS-OCT. Industry analysis & Market Report on IVUS-OCT is a syndicated market report, published as Global IVUS-OCT Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of IVUS-OCT market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.